Cargando…

Leptin Receptors can be an Alternative Target for New Anti-hypertensive Drug Development

Detalles Bibliográficos
Autores principales:	Ramkumar, Mridula, Kanthlal, S. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729687/ https://www.ncbi.nlm.nih.gov/pubmed/29285462 http://dx.doi.org/10.4103/ijem.IJEM_564_17

Ejemplares similares

Approach to loose teeth: An alternative solution
por: Gupta, Nishkarsh, et al.
Publicado: (2010)

Drug repositioning, a new alternative in infectious diseases
por: Serafin, Marissa Bolson, et al.
Publicado: (2018)

Can a laparoscopic surgery be an alternative to transjugular intrahepatic portosystemic shunts (TIPS) for the treatment of portal hypertensive bleeding?
por: Huang, Bin, et al.
Publicado: (2023)

Correspondence on Leptin Receptor Q223R Gene Polymorphism and Breast Cancer
por: Kebayoon, Amnuay, et al.
Publicado: (2022)

Leptin as an independent marker of metabolic syndrome
por: Joob, Beuy, et al.
Publicado: (2017)

Does Metformin Assist New Anti-Diabetic Drugs to Succeed?
por: Kastuyama, Hisayuki, et al.
Publicado: (2019)

Helicobacter pylori antibiotic resistance: Can herbal medicine be an alternative for the treatment?
por: Zamani, Mohammad, et al.
Publicado: (2016)

Can intraoral mask be a safe alternative for COVID-19 patients?
por: Aytaç, Betül Güven, et al.
Publicado: (2021)

Determination of Drug Compliance of Hypertensive Individuals
por: BAĞRIAÇIK, Ezgi, et al.
Publicado: (2017)

The Systematic Removal of Participants Post-Randomization Can Lead to Alternate Explanations of the Results
por: Cunningham, John A
Publicado: (2013)

Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection
por: Hwang, Ji-Hee, et al.
Publicado: (2016)

Is There any Alternative Receptor for SARS-CoV-2?
por: Shahriari Felordi, Mahtab, et al.
Publicado: (2021)

Obesity and insulin resistance are significant predictors of serum leptin levels
por: Beyazıt, Fatma, et al.
Publicado: (2017)

Recent developments on potential new applications of emetine as anti-cancer agent
por: Uzor, Philip F.
Publicado: (2016)

Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
por: Donia, Ahmed, et al.
Publicado: (2021)

Can we use Tramadol as an anti-shivering agent?
por: Joshi, Chhaya, et al.
Publicado: (2012)

A totally new system is needed for drug research and development
por: Gøtzsche, Peter C.
Publicado: (2018)

Before Plaque Enhancement Can Predict Stroke Recurrence, Alternative Etiologies Must Be Off the Table
por: Finsterer, Josef
Publicado: (2023)

Dronedarone: A New Therapeutic Alternative for Cardiac Arrhythmias
por: Upaganlawar, A, et al.
Publicado: (2010)

One minute sit-to-stand test as an alternative to measure functional capacity in patients with pulmonary arterial hypertension
por: Pereira, Monica C., et al.
Publicado: (2022)

Carcinogenic NMDA Contamination of Drugs for Heartburn, Hypertension and Diabetes
por: Ali, Meher Binte
Publicado: (2021)

Complementary and Alternative Medicine-related Drug-induced Liver Injury in Iran
por: Pasalar, Mehdi, et al.
Publicado: (2020)

Insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein and metabolic syndrome
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes
por: Yasri, Sora, et al.
Publicado: (2019)

Intranasal leptin improves survival after opioid overdose in a mouse model
por: Freire, Carla, et al.
Publicado: (2021)

The role of leptin in primary Sjögren syndrome: a clinical and histopathological assessment study
por: ERDOĞAN, Mustafa, et al.
Publicado: (2021)

Hyperkalemia from preoperative non-steroidal anti-inflammatory drugs and angiotensin II receptor blockers in patients with nephropathy
por: Song, Ho Kyung, et al.
Publicado: (2011)

Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?
por: Guo, Ying-Hua, et al.
Publicado: (2012)

Drug repositioning can accelerate discovery of pharmacological chaperones
por: Hay Mele, Bruno, et al.
Publicado: (2015)

Fatal drug errors in anaesthesia: Can we override?
por: Kumar, Amitabh, et al.
Publicado: (2014)

Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients
por: Baltodano-Calle, Maria J., et al.
Publicado: (2022)

Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
por: Dinoto, Alessandro, et al.
Publicado: (2020)

miRNA-122: Can it unravel an alternative pathway in early diagnosis and prognosis of type 2 diabetes mellitus?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
por: Freeman, Michael R., et al.
Publicado: (2019)

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination
por: Jeantin, Lina, et al.
Publicado: (2022)

Can the Target of 40% Stunting Reduction by 2024 Be Reached?
por: Siswati, Tri, et al.
Publicado: (2022)

Regarding “Endograft limb trimming and resheathing can be an alternative for emergent aortic repair without adequate stent graft availability”
por: Ysa, August, et al.
Publicado: (2017)

Can GPT-4 be a viable alternative for discussing complex cases in digital oral radiology? A critical analysis
por: Santana, Lucas Alves da Mota, et al.
Publicado: (2023)

Anti-oxidative trypanocidal drugs, myth or reality
por: Saeidnia, Soodabeh
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6khfg8se35f7m2o2ead3rspl64